Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 967.3	$ 617.9
Accounts receivable, less allowance for doubtful accounts	1,340.7	1,363.9
Inventories	2,492.2	2,385.0
Prepaid expenses and other current assets	352.4	357.1
Total Current Assets	5,152.6	4,723.9
Property, plant and equipment, net	2,042.5	2,077.4
Goodwill	9,038.8	9,599.7
Intangible assets, net	6,850.6	7,257.6
Other assets	941.0	980.1
Total Assets	24,025.5	24,638.7
Current Liabilities:
Accounts payable	334.8	400.9
Income taxes payable	120.7	126.7
Other current liabilities	1,360.7	1,413.9
Current portion of long-term debt	450.0	1,500.0
Total Current Liabilities	2,266.2	3,441.5
Deferred income taxes, net	747.8	840.1
Long-term income tax payable	699.7	685.1
Other long-term liabilities	593.4	557.8
Long-term debt	7,840.2	6,721.4
Total Liabilities	12,147.3	12,245.9
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 311.1 million shares in 2020 (309.9 million in 2019) issued	3.1	3.1
Paid-in capital	9,073.0	8,920.1
Retained earnings	9,802.9	10,427.3
Accumulated other comprehensive loss	(287.0)	(241.9)
Treasury stock, 103.8 million shares in 2020 (103.9 million shares in 2019)	(6,719.8)	(6,720.5)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	11,872.2	12,388.1
Noncontrolling interest	6.0	4.7
Total Stockholders' Equity	11,878.2	12,392.8
Total Liabilities and Stockholders' Equity	$ 24,025.5	$ 24,638.7